Arterez, Inc.
We have identified the multi-factorial upstream etiology or root causes of chronic vascular disease that can be characterized, cured and ultimately prevented.
- Stage Product In Development
- Industry Biotechnology
- Location White Lake, MI, USA
- Currency USD
- Founded January 2018
- Employees 3
- Incorporation Type C-corp
- Website Arterez.com
Company Summary
Cardiovascular Disease (CVD) is the world’s leading chronic killer impacting more than one-third of the world’s population. Dr. J.B. Tunac has discovered the multi-factorial root causes of chronic vascular disease and that those can be identified, characterized, cured and ultimately prevented. The company’s first drug, Embotricin™, targets healing at the cellular level aided by Arterez' proprietary diagnostic panel, Glycocardia.
Team
-
CEOMike is a serial entrepreneur and team leader with 15 years experience managing 24/7 high-tech operations followed by 15 years of entrepreneurship and strategic advisory leading, funding, growing and commercializing innovations across the spectrum of industries and technologies including startups and turnarounds. Mike graduated from The University of Detroit Jesuit, and Western Michigan; Psychology/Business Admin.
-
Dr. joe TunacChairman and PresidentDr. Tunac is a medical scientist specializing in the discovery & development of drugs and has 40 years of drug development experience for Merck, Warren Lambert Park Davis, Fermical and Farmaceutix where he discovered the anti-embolic mechanism. 30+ patents and patents pending and more than 35 scientific publications. Graduate studies at S. Dakota St. and Penn St., doctorate from Rutgers, NJ; The Waksman Institute: the birthplace of antibiotics
-
Brett HomovecCFOBrett gained his Corporate Finance/Mergers and Acquisitions experience as a VP in the Investment Banking Group for Rodman & Renshaw in New York and Chicago, Senior Associate in the Dean Witter Reynolds Corp Finance Group and as an audit professional for Touche Ross & Co. in New York. Brett graduated from Dartmouth College with a B.A. in Economics and received his MBA in Finance from New York University - Stern School of Business.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.